Alloway Paul
- SEC CIK
- 0001916155
No open-market purchases or sales filed in the past year.
Current role at each company
- QTTB Q32 Bio Inc.See Remarksas of Apr 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Alloway Paul as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2024 (view filing) | Mar 25 | 29 daysLate | Alloway PaulSee Remarks | SSale | −268 | $24.21 | −$6.49K | −9.4%2.60K after | |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | Alloway PaulSee Remarks | SSale | −7.28K | $0.57 | −$4.15K | −20.6%28.0K after | |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Alloway PaulSee Remarks | SSale | −11.0K | $1.45 | −$15.9K | −39.6%16.7K after | |
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Alloway PaulSee Remarks | SSale | −3.09K | $1.39 | −$4.30K | −13.3%20.1K after | From original |